Researchers have developed a sniff test that can detect which patients in a vegetative state following a TBI will regain consciousness. Read More
Advertisements
A simple smell test could help doctors to identify which patients in a vegetative state will recover. 100% of patients in a vegetative state who reacted to the sniff test went on to regain consciousness. 91% of those were still alive three years post-injury. Read More
MW189, a small molecule drug candidate, blocks abnormal inflammation in the brain which contributes to injury and disease induced neurological impairments. Read More
By inhibiting a particular receptor microglia use to survive, researchers reduced neuroinflammation and prompted recovery following traumatic brain injury in mouse models. Read More
Boys who exhibit inattention-hyperactivity by age 10 have an increased risk for traumatic brain injury later in life. Read More
Soldiers who suffer traumatic brain injury are significantly more likely than those who suffer other serious injuries to be diagnosed with mental health disorders including PTSD, schizophrenia, and anxiety. Read More
Study reveals the French Adrian helmet, a combat helmet from World War 1, performs better than modern designs in protecting from overhead blasts. Read More
Growth hormone replacement therapy for those with mild traumatic brain injury helped improve cognition, anxiety, and depression while reducing fatigue and sleep disturbances. Read More
Alzheimer's patients who used antipsychotics had a 29% increased risk of head injury and a 22% higher risk of TBI compared to others with the neurodegenerative disease who did not use the medications. Read More
Analyzing previous studies, researchers have identified the effects of individual and environmental risk factors for suicide over a person's lifespan. The risk factors, researchers report, change throughout a person's lifetime. Read More
Daily, early morning exposure to blue light therapy can help the healing process in people suffering from mild traumatic brain injury. Read More
A newly developed adeno-associated virus vector can deliver an anti-p Tau antibody directly to the hippocampus, significantly reducing pTau levels associated with CTE. Read More
